ピーク情報
|
（みょうが類） みょうが 花穂 生
neg
|
| Peak #3382 MN MID: SE113_S062801_M91 |
| m/z: 333.20724, RT: 79.00, 強度: 38750, ログ強度: 1.18, アダクト: [M-H]-, 共有数（同様のピークを含むサンプル数）: 3 |
| DB検索結果: (154 names) bicyclo-PGE2;(+)-Phomactin F;Phomactin F;5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R];1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid;... |
| DBごとのヒット数: ALL 128 KG 14 KN 74 HM 4 LM 36 |
| FlavonoidSearch最大スコア MS2: -, MS3: - |
DB検索結果
ppm
| 組成式 | 分子量 | 誤差(Δppm） | 候補化合物名（代表で最短名を記載） | 化合物ID |
|---|---|---|---|---|
| C20H30O4 | 334.21441 | 0.309 | bicyclo-PGE2 | HMDB: HMDB0060054, HMDB0249187 LipidMAPS: LMFA03010034 |
| C20H30O4 | 334.21441 | 0.309 | (+)-Phomactin F | KNApSAcK: C00016598 |
| C20H30O4 | 334.21441 | 0.309 | 5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R] | LipidMAPS: LMFA03110071, LMFA03110072, LMFA03110073, LMFA03110074 |
| C20H30O4 | 334.21441 | 0.309 | 1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid | KNApSAcK: C00011418 |
| C20H30O4 | 334.21441 | 0.309 | Lapidin | KNApSAcK: C00021406 |
| C20H30O4 | 334.21441 | 0.309 | 9-oxo-11R-hydroxy-5Z,13E-prostadienoic acid-1,15S-lactone | LipidMAPS: LMFA03010198 |
| C20H30O4 | 334.21441 | 0.309 | 12R,13R-dihydroxy-eicosa-5Z,8Z,10E,14Z,17Z-pentaenoic acid | LipidMAPS: LMFA03070060 |
| C20H30O4 | 334.21441 | 0.309 | Leoheteronin E | KNApSAcK: C00031965 |
| C20H30O4 | 334.21441 | 0.309 | Resolvin E3 | HMDB: HMDB0257164 LipidMAPS: LMFA03140006, LMFA03140007 |
| C20H30O4 | 334.21441 | 0.309 | Delta-12-Prostaglandin J2 | HMDB: HMDB0004238, HMDB0247550 KEGG: C05958 LipidMAPS: LMFA03010020 |
| C20H30O4 | 334.21441 | 0.309 | 14,15-epoxy-13-hydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid | LipidMAPS: LMFA03060117 |
| C20H30O4 | 334.21441 | 0.309 | Pachyclavulariolide N | KNApSAcK: C00044990, C00044991 |
| C20H30O4 | 334.21441 | 0.309 | Resolvin E2 | HMDB: HMDB0257163 KEGG: C18173 LipidMAPS: LMFA03140004, LMFA03140011 |
| C20H30O4 | 334.21441 | 0.309 | (5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-hydroxypropyl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid | LipidMAPS: LMFA04000105 |
| C20H30O4 | 334.21441 | 0.309 | Acanthokoreoic acid A | KNApSAcK: C00031557 |
| C20H30O4 | 334.21441 | 0.309 | Kolavic acid | KNApSAcK: C00023484, C00023486 |
| C20H30O4 | 334.21441 | 0.309 | ent-16-Hydroxy-17-oxo-7,13Z-Labdadiene-15-oic acid | KNApSAcK: C00022741 |
| C20H30O4 | 334.21441 | 0.309 | Sinulariolide | KNApSAcK: C00040316 |
| C20H30O4 | 334.21441 | 0.309 | Preleoheterin | KNApSAcK: C00035728 |
| C20H30O4 | 334.21441 | 0.309 | ent-8beta,17-Epoxy-3-oxo-13Z-labden-15-oic acid | KNApSAcK: C00022516 |
| C20H30O4 | 334.21441 | 0.309 | Agathic acid | HMDB: HMDB0036828, HMDB0248058 KNApSAcK: C00022522, C00022526, C00041322 |
| C20H30O4 | 334.21441 | 0.309 | 7'-Carboxy-gamma-chromanol | HMDB: HMDB0012850 |
| C20H30O4 | 334.21441 | 0.309 | Prostaglandin A2 | HMDB: HMDB0002752, HMDB0242292, HMDB0302203 KEGG: C05953 LipidMAPS: LMFA03010035, LMFA03010092, LMFA03010100, LMFA03110137, LMFA03110138, LMFA03110139, LMFA03110140, LMFA03110141, LMFA03110142 |
| C20H30O4 | 334.21441 | 0.309 | 8,9-epoxy-7-hydroxy-5Z,11Z,14Z,17Z-eicosatetraenoic acid | LipidMAPS: LMFA03060116 |
| C20H30O4 | 334.21441 | 0.309 | Alboatisin C | KNApSAcK: C00038400 |
| C20H30O4 | 334.21441 | 0.309 | 12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R] | LipidMAPS: LMFA03110086, LMFA03110087, LMFA03110088, LMFA03110089, LMFA03110272, LMFA03110273, LMFA03110274, LMFA03110275 |
| C20H30O4 | 334.21441 | 0.309 | 15S-hydroperoxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070013 |
| C20H30O4 | 334.21441 | 0.309 | Vaginatin | HMDB: HMDB0035286 KNApSAcK: C00021410 |
| C20H30O4 | 334.21441 | 0.309 | Prostaglandin B2 | HMDB: HMDB0004236, HMDB0302205 KEGG: C05954 LipidMAPS: LMFA03010018, LMFA03010235 |
| C20H30O4 | 334.21441 | 0.309 | Sch 49027 | KNApSAcK: C00016813 |
| C20H30O4 | 334.21441 | 0.309 | Prostaglandin C2 | HMDB: HMDB0060095 KEGG: C05955 LipidMAPS: LMFA03010133 |
| C20H30O4 | 334.21441 | 0.309 | Dihydrocapsiconiate | KNApSAcK: C00033774 |
| C20H30O4 | 334.21441 | 0.309 | 14,15-epoxy-16-hydroxy-5Z,8Z,11Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03060115 |
| C20H30O4 | 334.21441 | 0.309 | Crassocolide D | KNApSAcK: C00041458 |
| C20H30O4 | 334.21441 | 0.309 | Caesalpinolide D | KNApSAcK: C00048342 |
| C20H30O4 | 334.21441 | 0.309 | Leoheterin | KNApSAcK: C00031960 |
| C20H30O4 | 334.21441 | 0.309 | Topsentolide B1 | KNApSAcK: C00041940 |
| C20H30O4 | 334.21441 | 0.309 | 14-hydroperoxy-5Z,8Z,11Z,15E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070056 |
| C20H30O4 | 334.21441 | 0.309 | 15-Keto-13,14-dihydroprostaglandin A2 | HMDB: HMDB0001244 LipidMAPS: LMFA03010033 |
| C20H30O4 | 334.21441 | 0.309 | Phlogantholide A | KNApSAcK: C00022230 |
| C20H30O4 | 334.21441 | 0.309 | Flexibilide | KNApSAcK: C00039215 |
| C20H30O4 | 334.21441 | 0.309 | (S,5Z,9E)-8-hydroxy-10-((1S,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | LipidMAPS: LMFA03110263, LMFA03110264, LMFA03110265, LMFA03110266, LMFA03110267, LMFA03110268, LMFA03110269, LMFA03110270 |
| C20H30O4 | 334.21441 | 0.309 | 1(10),13E-Halimadiene-15,18-dioic acid | KNApSAcK: C00023449, C00023451 |
| C20H30O4 | 334.21441 | 0.309 | 16-Hydroxy-6-oxo-7,ent-13E-labdasien-15-oic acid | KNApSAcK: C00022430 |
| C20H30O4 | 334.21441 | 0.309 | Isodopharicin D | KNApSAcK: C00050918 |
| C20H30O4 | 334.21441 | 0.309 | 5,6-Epoxytetraene | KEGG: C14815 LipidMAPS: LMFA03060075 |
| C20H30O4 | 334.21441 | 0.309 | Decahydro-alpha,4a-dimethyl-8-methylene-7-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid | KNApSAcK: C00012848 |
| C20H30O4 | 334.21441 | 0.309 | Hartwrightia acid | KNApSAcK: C00022423 |
| C20H30O4 | 334.21441 | 0.309 | [4aR-(4aalpha,5alpha,6alpha,8abeta)]-4,4a,5,6,7,8,8a,9-Octahydro-5-hydroxy-3,5,8a-trimethylnaphtho[2,3-b]furan-6-yl ester3-methylbutanoic acid | KNApSAcK: C00012905 |
| C20H30O4 | 334.21441 | 0.309 | 5S-hydroxy-9-oxo-6E,10,14Z-prostatrienoic acid-cyclo[8S,12R] | LipidMAPS: LMFA03110255, LMFA03110256, LMFA03110257, LMFA03110258, LMFA03110259, LMFA03110260, LMFA03110261, LMFA03110262 |
| C20H30O4 | 334.21441 | 0.309 | Cymbodiacetal | KNApSAcK: C00010811 |
| C20H30O4 | 334.21441 | 0.309 | 12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070012 |
| C20H30O4 | 334.21441 | 0.309 | Neoallocyathin A4 | KNApSAcK: C00023685 |
| C20H30O4 | 334.21441 | 0.309 | 14-Deoxyandrographolide | HMDB: HMDB0244579 KNApSAcK: C00022232 |
| C20H30O4 | 334.21441 | 0.309 | (R,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid | LipidMAPS: LMFA03110276, LMFA03110277, LMFA03110278, LMFA03110279 |
| C20H30O4 | 334.21441 | 0.309 | Serrulat-14-en-3,7,8,20-tetraol | KNApSAcK: C00040283 |
| C20H30O4 | 334.21441 | 0.309 | 12,18-dihydroxy-5Z,8Z,10E,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070051 |
| C20H30O4 | 334.21441 | 0.309 | 12-Keto-leukotriene B4 | HMDB: HMDB0004234 KEGG: C05949 LipidMAPS: LMFA03020024 |
| C20H30O4 | 334.21441 | 0.309 | Mebadonin | KNApSAcK: C00051518 |
| C20H30O4 | 334.21441 | 0.309 | Leukotriene B5 | HMDB: HMDB0005073, HMDB0062486, HMDB0247478 LipidMAPS: LMFA03020010 |
| C20H30O4 | 334.21441 | 0.309 | Leopersin G | KNApSAcK: C00050374 |
| C20H30O4 | 334.21441 | 0.309 | Mayolide A | KNApSAcK: C00042722 |
| C20H30O4 | 334.21441 | 0.309 | Hallerin | KNApSAcK: C00012174 |
| C20H30O4 | 334.21441 | 0.309 | 9S-hydroperoxy-5Z,7E,11Z,14Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070057 |
| C20H30O4 | 334.21441 | 0.309 | 5-oxo-12-HETE | HMDB: HMDB0012824, HMDB0062423 LipidMAPS: LMFA03020069 |
| C20H30O4 | 334.21441 | 0.309 | 5S-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070001, LMFA03070059 |
| C20H30O4 | 334.21441 | 0.309 | 7,13(16)-Labdadiene-15,19-dioic acid | KNApSAcK: C00022442 |
| C20H30O4 | 334.21441 | 0.309 | 9S,11R-dihydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone | LipidMAPS: LMFA03010197 |
| C20H30O4 | 334.21441 | 0.309 | 18-Oxogrindelic acid | KNApSAcK: C00022629 |
| C20H30O4 | 334.21441 | 0.309 | Manaarenolide I | KNApSAcK: C00041657 |
| C20H30O4 | 334.21441 | 0.309 | Excoecarin V2 | KNApSAcK: C00031782 |
| C20H30O4 | 334.21441 | 0.309 | 4-((1R,2R)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | LipidMAPS: LMFA03110247, LMFA03110248, LMFA03110249, LMFA03110250, LMFA03110251, LMFA03110252, LMFA03110253, LMFA03110254 |
| C20H30O4 | 334.21441 | 0.309 | 3,4-Dihexylphthalic Acid | HMDB: HMDB0258114 |
| C20H30O4 | 334.21441 | 0.309 | Floridicin | KNApSAcK: C00047045 |
| C20H30O4 | 334.21441 | 0.309 | 17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetate | KEGG: C14913 |
| C20H30O4 | 334.21441 | 0.309 | Manaarenolide G | KNApSAcK: C00041655, C00041656 |
| C20H30O4 | 334.21441 | 0.309 | 5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | LipidMAPS: LMFA03020017 |
| C20H30O4 | 334.21441 | 0.309 | 9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid | LipidMAPS: LMFA04000095 |
| C20H30O4 | 334.21441 | 0.309 | LipidMAPS: LMPR0104090001 |
|
| C20H30O4 | 334.21441 | 0.309 | 17,18-Dihydroxy-2,6,10,14-phytatetraen-1,20-olide | KNApSAcK: C00022129, C00022130 |
| C20H30O4 | 334.21441 | 0.309 | Scapanin A | KNApSAcK: C00022258 |
| C20H30O4 | 334.21441 | 0.309 | 3-O-Angeloylcuauhtemone | KNApSAcK: C00012696 |
| C20H30O4 | 334.21441 | 0.309 | LipidMAPS: LMPR0104180004 |
|
| C20H30O4 | 334.21441 | 0.309 | 17-Oxogrindelic acid | KEGG: C09150 KNApSAcK: C00003462 |
| C20H30O4 | 334.21441 | 0.309 | Phyllostachysin F | KNApSAcK: C00034948 |
| C20H30O4 | 334.21441 | 0.309 | Excoecarin V1 | KNApSAcK: C00031781 |
| C20H30O4 | 334.21441 | 0.309 | 12,20-Dihydroxy-3alpha,4alpha,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene | KNApSAcK: C00022538 |
| C20H30O4 | 334.21441 | 0.309 | Phytocassane B | HMDB: HMDB0041055 KNApSAcK: C00034141 |
| C20H30O4 | 334.21441 | 0.309 | 8betaH,ent-3eta,17-Dioxo-13Z-labden-15-oic acid | KNApSAcK: C00022435, C00022437 |
| C20H30O4 | 334.21441 | 0.309 | (E,E,E)-2-(4,8,12-Trimethyl-3,7,11-tridecatrienyl)-2-butenedioic acid | KNApSAcK: C00016237 |
| C20H30O4 | 334.21441 | 0.309 | 5Z,8Z,11Z,14Z-Eicosatetraenedioic acid | LipidMAPS: LMFA01170034 |
| C20H30O4 | 334.21441 | 0.309 | Di-n-hexyl phthalate | HMDB: HMDB0251287 KEGG: C14504 |
| C20H30O4 | 334.21441 | 0.309 | Hypoglicin A | KNApSAcK: C00055916 |
| C20H30O4 | 334.21441 | 0.309 | ent-2,3-Seco-beyer-15-ene-2,3-dioic acid | KNApSAcK: C00049148 |
| C20H30O4 | 334.21441 | 0.309 | 6-Oxogrindelic acid | KNApSAcK: C00022623 |
| C20H30O4 | 334.21441 | 0.309 | Cyathin A4 | KNApSAcK: C00023678 |
| C20H30O4 | 334.21441 | 0.309 | 5S,15S-dihydroxy-6E,8Z,11Z,13E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03140013 |
| C20H30O4 | 334.21441 | 0.309 | Zerumin B | KNApSAcK: C00043123 |
| C20H30O4 | 334.21441 | 0.309 | Batudioic acid | KNApSAcK: C00022441 |
| C20H30O4 | 334.21441 | 0.309 | 8R-HPETE | KNApSAcK: C00000422 |
| C20H30O4 | 334.21441 | 0.309 | (ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid | HMDB: HMDB0036760 |
| C20H30O4 | 334.21441 | 0.309 | Chapecoderin A | KNApSAcK: C00046662 |
| C20H30O4 | 334.21441 | 0.309 | 18R-hydroperoxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070043 |
| C20H30O4 | 334.21441 | 0.309 | 3beta,13-Dihydroxy-16-(hydroxymethylene)-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone | KEGG: C15159 |
| C20H30O4 | 334.21441 | 0.309 | Isoscoparin L | KNApSAcK: C00047259 |
| C20H30O4 | 334.21441 | 0.309 | 15d PGD2 | HMDB: HMDB0060046, HMDB0062298 LipidMAPS: LMFA03010051 |
| C20H30O4 | 334.21441 | 0.309 | 8,18-dihydroxy-5Z,9E,11Z,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070052 |
| C20H30O4 | 334.21441 | 0.309 | Phomactin A | KNApSAcK: C00016814 |
| C20H30O4 | 334.21441 | 0.309 | Enanderianin P | KNApSAcK: C00030178 |
| C20H30O4 | 334.21441 | 0.309 | Prostaglandin J2 | HMDB: HMDB0002710, HMDB0247117 KEGG: C05957 LipidMAPS: LMFA03010019, LMFA03110100, LMFA03110101, LMFA03110102, LMFA03110103, LMFA03110114, LMFA03110133, LMFA03110135 |
| C20H30O4 | 334.21441 | 0.309 | ent-2alpha-2,18-Dihydroxy-8(17),13-labdadien-15,16-olide | KNApSAcK: C00022229 |
| C20H30O4 | 334.21441 | 0.309 | 3alpha,12-Dihydroxy-4alpha,20,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene | KNApSAcK: C00022539 |
| C20H30O4 | 334.21441 | 0.309 | Pseurata A | KNApSAcK: C00047547, C00047616 |
| C20H30O4 | 334.21441 | 0.309 | 3-Oxo-18-hydroxy-8(17),13Z-labdadien-15-oic acid | KNApSAcK: C00022492 |
| C20H30O4 | 334.21441 | 0.309 | Cyafrin A4 | KNApSAcK: C00023686 |
| C20H30O4 | 334.21441 | 0.309 | 6beta,7beta-Dihydroxykaurenoic acid | HMDB: HMDB0036763 KEGG: C11876 |
| C20H30O4 | 334.21441 | 0.309 | 8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R] | LipidMAPS: LMFA03110058, LMFA03110059, LMFA03110060, LMFA03110061, LMFA03110280, LMFA03110281, LMFA03110282, LMFA03110283 |
| C20H30O4 | 334.21441 | 0.309 | LipidMAPS: LMPR0104480003 |
|
| C20H30O4 | 334.21441 | 0.309 | [R-[R*,R*-(Z,E,E,E)]]-1-(3,3-Dimethyloxiranyl)-9-hydroxy-3,7-dimethyl-3,5,7-nonatrienyl ester 2-methyl-2-butenoic acid | KNApSAcK: C00011419 |
| C20H30O4 | 334.21441 | 0.309 | 8alpha-8-Hydroxy-12-oxo-13-abieten-18-oic acid | HMDB: HMDB0035878 |
| C20H30O4 | 334.21441 | 0.309 | 9S,15S-dihydroxy-5Z,7E,11Z,13E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070061 |
| C20H30O4 | 334.21441 | 0.309 | Decahydro-alpha,4a-dimethyl-8-methylene-7-[(3-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid | KNApSAcK: C00012847 |
| C20H30O4 | 334.21441 | 0.309 | LipidMAPS: LMPR0104310001 |
|
| C20H30O4 | 334.21441 | 0.309 | Henrilabdane C | KNApSAcK: C00033909 |
| C20H30O4 | 334.21441 | 0.309 | Chapecoderin B | KNApSAcK: C00046663 |
| C20H30O4 | 334.21441 | 0.309 | Kamebanin | KNApSAcK: C00047260, C00047479 |
| C20H30O4 | 334.21441 | 0.309 | Caesalpinolide C | KNApSAcK: C00048341 |
| C20H30O4 | 334.21441 | 0.309 | 11,18-dihydroxy-5Z,8Z,12E,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070050 |
| C20H30O4 | 334.21441 | 0.309 | Sandensolide | KNApSAcK: C00050213 |
| C20H30O4 | 334.21441 | 0.309 | Lathyrol | KEGG: C09125 KNApSAcK: C00003450 |